Form 8-K - Current report:
SEC Accession No. 0001564590-21-040845
Filing Date
2021-08-04
Accepted
2021-08-04 16:23:37
Documents
13
Period of Report
2021-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sana-8k_20210804.htm   iXBRL 8-K 35329
2 EX-99.1 sana-ex991_6.htm EX-99.1 402969
  Complete submission text file 0001564590-21-040845.txt   593206

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sana-20210804.xsd EX-101.SCH 5744
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20210804_lab.xml EX-101.LAB 20227
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20210804_pre.xml EX-101.PRE 12060
6 EXTRACTED XBRL INSTANCE DOCUMENT sana-8k_20210804_htm.xml XML 3688
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 211144356
SIC: 2836 Biological Products, (No Diagnostic Substances)